Business Context and Reporting Period
Marchex, Inc. filed this Form 8-K on July 27, 2005, to report the completion of the acquisition of IndustryBrains, Inc. (IB), a New York corporation. The transaction was executed through a two-step merger structure involving Marchex subsidiaries Einstein Holdings I, Inc. and Einstein Holdings 2, LLC, intended to qualify as a tax-free reorganization under Section 368 of the Internal Revenue Code.
Key Financial Metrics and Transaction Details
- Total Merger Consideration: $30,522,500
- Cash Consideration: $15,522,500
- Equity Consideration: $15,000,000 in Class B common stock (valued based on the 30-day average closing price ending July 21, 2005)
- Restricted Equity: $2,750,000 of the equity consideration issued to IB employee shareholders is subject to a 2.5-year vesting schedule.
- Escrow Amount: $4,725,000 total ($2,475,000 cash and $2,250,000 equity) held for 12 months to secure indemnification obligations.
- Transaction Costs: $977,500 investment banking fee paid to RBC Capital Markets, plus additional costs.
- Funding Source: Cash on hand.
Material Changes and Agreements
The primary material change is the consolidation of IndustryBrains, Inc. into Marchex, Inc. Key contractual terms include:
- Non-Competition: Principal shareholders of IB are bound by non-competition covenants for two years post-closing.
- Employment: Principal shareholders entered into employment agreements effective at closing.
- Registration Rights: Marchex agreed to file a Form S-3 registration statement for the resale of issued equity shares within 45 days of closing.
- Indemnification: Former IB shareholders must indemnify Marchex for certain liabilities, secured by the escrowed funds.
Outlook, Risks, and Unusual Items
The filing does not provide specific forward-looking guidance, revenue projections, or management commentary regarding future performance. The transaction was determined through arm's-length negotiation. A material contingency noted is the requirement to file financial statements of the acquired business and pro forma financial information within 71 calendar days if required by the SEC. The equity issuance was made under Section 4(2) of the Securities Act of 1933 as a private placement exemption.
Investor Verification Checklist
- Verify the final valuation of the $15,000,000 equity consideration based on the specific 30-day average market price.
- Review the full text of the Merger Agreement (Exhibit 2.1) for detailed representations, warranties, and indemnification limitations.
- Monitor the upcoming filing of IB's financial statements and pro forma information within the 71-day window.
- Confirm the successful filing of the Form S-3 registration statement for the resale of Class B common stock within 45 days.
- Assess the impact of the $977,500 transaction fee and cash outflow on Marchex's immediate liquidity position.